REFERENCES:

1. Ikeda, H. et al. The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells. Breast Cancer Res. BCR 12, R43 (2010).

2. Wang, K. et al. Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy. Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med. 34, 33–38 (2013).

3. Yavuz, B. B., Aktan, M. & Kanyilmaz, G. Prognostic Factors in Patients with Triple Negative Breast Cancer Undergoing Adjuvant Radiotherapy: A 10-Year Single Center Experience: Triple negative breast cancer. Arch. Breast Cancer 377–385 (2022) doi:10.32768/abc.202293377-385.

4. Yao, Y., Li, J., Hu, H., Xu, T. & Chen, Y. Ultrasound-guided serratus plane block enhances pain relief and quality of recovery after breast cancer surgery: A randomised controlled trial. Eur. J. Anaesthesiol. 36, 436–441 (2019).

5. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials – The Lancet. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00285-4/fulltext (2023).

6. Le, T. T. The Neuronal Identity of Triple Negative Breast Cancer – ProQuest. Tufts University ProQuest Dissertations Publishing https://www.proquest.com/openview/0285152ccf51e9a972961af568734406/1.pdf?pq-origsite=gscholar&cbl=18750&diss=y.

7. Vicente, J. J. & Wordeman, L. The quantification and regulation of microtubule dynamics in the mitotic spindle. Curr. Opin. Cell Biol. 60, 36–43 (2019).

8. Le, T. T. et al. Sensory nerves enhance triple-negative breast cancer invasion and metastasis via the axon guidance molecule PlexinB3. NPJ Breast Cancer 8, 116 (2022).

9. Lebok, P. et al. High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer. Oncol. Lett. 11, 1987–1994 (2016).

10. O’Reilly, D., Sendi, M. A. & Kelly, C. M. Overview of recent advances in metastatic triple negative breast cancer. World J. Clin. Oncol. 12, 164–182 (2021).

11. Harbeck, N. et al. Breast cancer. Nat. Rev. Dis. Primer 5, 1–31 (2019).

12. Metastatic Breast Cancer – Symptoms, Diagnosis & More. https://www.breastcancer.org/types/metastatic.

13. Characteristics of triple-negative breast cancer – PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018596/.

14. Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121, 2750–2767 (2011).

15. Yang, D. et al. Axon-like protrusions promote small cell lung cancer migration and metastasis. eLife 8, e50616 (2019).

16. Panda, D., Miller, H. P. & Wilson, L. Rapid treadmilling of brain microtubules free of microtubule-associated proteins in vitro and its suppression by tau. Proc. Natl. Acad. Sci. U. S. A. 96, 12459–12464 (1999).

17. Feinstein, S. C. & Wilson, L. Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death. Biochim. Biophys. Acta 1739, 268–279 (2005).

18. Fan, Y. & Guo, Y. Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway. Int. J. Clin. Exp. Pathol. 8, 10420–10427 (2015).